Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Can infections trigger autoimmunity, and do IgG or negative blood PCR results prove active infection or cure?

Infections can contribute to autoimmunity, but pathogen-specific IgG usually reflects prior exposure and a negative blood PCR alone does not prove ongoing infection or eradication.

PlausibleSeptember 23, 202614 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Infections can trigger autoimmunity through molecular mimicry and bystander inflammation, but pathogen-specific IgG generally indicates prior immune exposure and a negative blood PCR does not by itself prove either ongoing tissue infection or complete eradication.

laying out figure…
5 of 7 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says infections may trigger autoimmune pathology through molecular mimicry and bystander inflammation. It also frames IgG as a marker of past immune exposure rather than proof of active infection, while negative blood PCR is not enough on its own to confirm persistence or cure. The mechanism graph supports these interpretations by linking infection to immune cross-reactivity, inflammatory activation, and the limits of blood-based testing.

Verified conclusion

Infections can contribute to autoimmune pathology, but laboratory results must be interpreted in relation to pathogen biology, timing, treatment, and the clinical syndrome—not as stand-alone proof of either persistence or cure.

Autoimmune mechanisms

  • Molecular mimicry is directly established in Campylobacter jejuni–associated Guillain–Barré syndrome: bacterial sialylated lipooligosaccharides resemble nerve gangliosides (including GM1, GD1a, and GQ1b). Infection-induced cross-reactive antibodies activate complement and damage peripheral-nerve membranes; experimental monoclonal antibodies can produce paralysis in nerve–muscle preparations.
  • In other diseases, mimicry may contribute but is less definitively causal. For example, in a military cohort, EBV seroconversion preceded multiple-sclerosis onset in 34 of 35 initially seronegative cases, with approximately a 32-fold increased MS risk; cross-reactive EBV/myelin immune responses are biologically plausible.
  • Bystander inflammation provides a complementary route: innate sensing, cytokines, antigen-presenting-cell activation, costimulation, and infection-related tissue injury can activate autoreactive T and B cells without pathogen–self cross-reactivity. Tissue damage releases self-antigens and can promote epitope spreading, amplifying injury. This mechanism is strongly supported experimentally, though attribution to a particular human autoimmune onset is often less certain.

Interpreting infection tests

  • Pathogen-specific IgG generally documents prior immune exposure, not viable ongoing infection or a reason for treatment alone. Anaplasma IgG can persist for months and occasionally up to 4 years; Borrelia IgG for years to decades; and Babesia IgG for at least a year after clearance.
  • A negative blood PCR means DNA was not detected in that specimen at that time. It is not a test of cure and does not resolve possible extravascular infection. Blood PCR is relatively insensitive for Borrelia; for anaplasmosis, sensitivity can fall within 48 hours of effective doxycycline. For babesiosis, PCR negativity alone likewise does not establish eradication.

Bottom line

  • The claim is well supported: infections can trigger or amplify autoimmunity through mimicry and inflammatory bystander pathways; positive IgG usually indicates past exposure, while negative blood PCR alone proves neither persistent tissue infection nor complete eradication.

References

  1. Guillain-Barré syndrome: expanding the concept of molecular mimicry — pmc.ncbi.nlm.nih.gov ↗
  2. Monoclonal antibodies raised against Guillain-Barré syndrome–associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations — jci.org ↗
  3. Ganglioside Molecular Mimicry and Its Pathological Roles in Guillain-Barré Syndrome and Related Diseases | Infection and Immunity — journals.asm.org ↗
  4. For personal use. Only reproduce with permission from The Lancet Publishing Group. — thelancet.com ↗
  5. Mechanisms governing bystander activation of T cells - Frontiers — frontiersin.org ↗
  6. Infectious diseases, autoantibodies, and autoimmunity - PMC — pmc.ncbi.nlm.nih.gov ↗
  7. Mechanisms for the induction of autoimmunity by infectious agents — jci.org ↗
  8. The Role of Viral Infections in the Onset of Autoimmune ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  9. Clinical Testing and Diagnosis for Anaplasmosis - CDC — cdc.gov ↗
  10. Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States — wwwnc.cdc.gov ↗
  11. Laboratory Diagnosis of Lyme Borreliosis - PMC — pmc.ncbi.nlm.nih.gov ↗
  12. Anaplasma – PCR and Antibody - Public Health Ontario — publichealthontario.ca ↗
  13. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis — academic.oup.com ↗
  14. Post-infectious neurological disorders - Kyle M. Blackburn, Cynthia Wang, 2020 — journals.sagepub.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Unsupported4 sourcesDoes a positive Anaplasma IgM alone diagnose active anaplasmosis?→Plausible13 sourcesCan gliotoxin and mycophenolic acid alter immune processes without proving neural autoimmunity?→